Therapy Areas: Devices
DDL introduces Pharmaceutical Consulting Services for drug delivery support and combination product development
18 November 2026 -

DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services programme designed to help pharmaceutical and drug delivery companies navigate complex development challenges, reduce risk and accelerate product development.

The new consulting services provide expert guidance across pharmaceutical primary packaging, containment and delivery systems, and combination products. By integrating technical consulting with DDL's established laboratory testing capabilities, the services aim to help companies develop effective, phase-appropriate testing strategies and address potential challenges before they lead to costly rework or delays.

"Decisions made early in pharmaceutical packaging and drug delivery development can have significant implications for product performance, quality and regulatory success," said Jennifer Riter, vice president of Analytical Testing Services at DDL. "Our goal is to help customers make informed technical decisions, identify potential risks and develop testing strategies that support successful product development from initial concept through commercialisation."

Login
Username:

Password: